110 related articles for article (PubMed ID: 6155208)
21. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
22. Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.
Luikart SD; Kennealey GT; Kirkwood JM
J Clin Oncol; 1984 Mar; 2(3):164-8. PubMed ID: 6199481
[TBL] [Abstract][Full Text] [Related]
23. [A case of alpha-fetoprotein producing primary intracranial embryonal carcinoma treated with combination chemotherapy with cis-platinum, vinblastine and bleomycin (author's transl)].
Nakajima F; Pak S; Fujitsu K; Kuwabara T
No Shinkei Geka; 1981; 9(3):371-5. PubMed ID: 6165918
[TBL] [Abstract][Full Text] [Related]
24. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin.
Corral DA; Sella A; Pettaway CA; Amato RJ; Jones DM; Ellerhorst J
J Urol; 1998 Nov; 160(5):1770-4. PubMed ID: 9783949
[TBL] [Abstract][Full Text] [Related]
25. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY
Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073
[TBL] [Abstract][Full Text] [Related]
26. Reduced platelet survival following chemotherapy with vinblastine, bleomycin and cis-platinum for testicular teratoma.
Rees GJ; Slade RR; Hopes P
Eur J Cancer Clin Oncol; 1982 Nov; 18(11):1125-9. PubMed ID: 6186497
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of the combination of vinblastine plus cisplatin administered by continuous 120-hour infusion for patients with advanced malignant melanoma.
Creagan ET; Ahmann DL; Schutt AJ; Schaid DJ
Cancer Treat Rep; 1987; 71(7-8):769-70. PubMed ID: 3607788
[No Abstract] [Full Text] [Related]
28. Long-term treatment with cis-dichlorodiammineplatinum(II)-vinblastine-bleomycin: possible association with severe coronary artery disease.
Edwards GS; Lane M; Smith FE
Cancer Treat Rep; 1979 Apr; 63(4):551-2. PubMed ID: 87274
[No Abstract] [Full Text] [Related]
29. Phase I clinical trial of combined therapy with vinblastine (NSC-49842), bleomycin (NSC-125066), and cisdichlorodiammineplatinum(II)( NSC-119875).
Samson MK; Baker LH; Devos JM; Buroker TR; Izbicki RM; Vaitkevicius VK
Cancer Treat Rep; 1976 Jan; 60(1):91-7. PubMed ID: 63332
[TBL] [Abstract][Full Text] [Related]
30. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
[TBL] [Abstract][Full Text] [Related]
31. [Treatment of non-seminomatous testicular tumors in combination with vinblastine/bleomycin and adriamycin/cisplatin].
Boewer C; Fleck H; Uibel M; Nawka S
Z Urol Nephrol; 1982 May; 75(5):315-23. PubMed ID: 6180571
[TBL] [Abstract][Full Text] [Related]
32. Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer.
Thongprasert S; Chewaskulyong B
J Med Assoc Thai; 2004 Oct; 87(10):1162-7. PubMed ID: 15560691
[TBL] [Abstract][Full Text] [Related]
33. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
34. Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM).
Ervin TJ; Weichselbaum R; Miller D; Meshad M; Posner M; Fabian R
Cancer Treat Rep; 1981; 65(9-10):787-91. PubMed ID: 6168371
[TBL] [Abstract][Full Text] [Related]
35. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
Hsu CH; Chen J; Wu CY; Cheng AL; Pu YS
Anticancer Res; 2001; 21(1B):711-5. PubMed ID: 11299831
[TBL] [Abstract][Full Text] [Related]
36. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin, bleomycin, and vinblastine combination therapy of testicular tumors: an analysis.
D'Aoust JC; Prestayko AW; Einhorn LH; Comis RL; Ginsberg SJ; Archambault WA; Crooke ST
Med Pediatr Oncol; 1979; 6(3):195-205. PubMed ID: 89624
[TBL] [Abstract][Full Text] [Related]
38. Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin.
Kelsen DP; Bains M; Hilaris B; Chapman R; McCormack P; Alexander J; Hopfan S; Martini N
Cancer; 1982 Mar; 49(6):1174-7. PubMed ID: 6174199
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin, vinblastine, and bleomycin combination therapy in resistant gestational trophoblastic disease.
Gordon AN; Kavanagh JJ; Gershenson DM; Saul PB; Copeland LJ; Stringer CA
Cancer; 1986 Oct; 58(7):1407-10. PubMed ID: 2427185
[TBL] [Abstract][Full Text] [Related]
40. Inclusion of cisplatinum (cis-DDP, Platidiam, Lachema) into combined chemotherapeutic protocol for the treatment of testicular cancer.
Bodrogi I; Baki M; Hindy I; Eckhardt S
Neoplasma; 1983; 30(5):557-61. PubMed ID: 6197662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
